Last reviewed · How we verify

NCT03744884

Movement Characterization in Spastic/Dystonic Cerebral Palsy Using Haptic Feedback in Virtual Reality

Status unknown NA Last updated 3 January 2020
What this trial tests

NA trial testing Force efforts with haptic feedback in virtual reality. in Cerebral Palsy, Mixed in 68 participants. Status unknown.

Timeline
1 December 2018
Primary endpoint
1 January 2021
1 January 2021

Quick facts

Lead sponsorUniversity of Illinois at Urbana-Champaign
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposediagnostic
Enrollment68
Start date1 December 2018
Primary completion1 January 2021
Estimated completion1 January 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Illinois at Urbana-Champaign

Who can join

Adults 7 to 17, any sex, with Cerebral Palsy, Mixed or Cerebral Palsy, Spastic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This game-like intervention using virtual reality will provide an objective and quantitative characterization of dystonia and spasticity presentations in cerebral palsy, even if combined, through the process of motor learning. This intervention could have a therapeutic benefit in the rehabilitation of children with cerebral palsy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Rehabilitation for Children With Dystonic Cerebral Palsy Using Haptic Feedback in Virtual Reality: Protocol for a Randomized Controlled Trial.
    McNish RN, Chembrammel P, Speidel NC, Lin JJ, et al · · 2019 · cited 3× · PMID 31344678 · DOI 10.2196/11470

Verify or expand the search:

Other University of Illinois at Urbana-Champaign trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03744884.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing